# CREON for the Treatment of Post-RYGB Hypoglycemia

> **NCT02733848** · PHASE1 · TERMINATED · sponsor: **East Carolina University** · enrollment: 5 (estimated)

## Conditions studied

- Hypoglycemia

## Interventions

- **DRUG:** Creon
- **OTHER:** Diet
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02733848
- **Lead sponsor:** East Carolina University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 5 (ESTIMATED)
- **Why stopped:** Lack of funding
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733848, "CREON for the Treatment of Post-RYGB Hypoglycemia". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02733848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*